Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”
Joint Authors
Chong, Pee-Win
Bongartz, Udo
Seibt, Stephanie
Bothe, Gordana
Uebelhack, Ralf
Wszelaki, Natalia
De Costa, Patricia
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-07-11
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
In the article titled “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects” [1], there was an error in the legend of Figure 3 that occurred during the production stage, as the color of the placebo results/bars has been replaced by the colors of the high dose results/bars and vice versa.
American Psychological Association (APA)
Uebelhack, Ralf& Bongartz, Udo& Seibt, Stephanie& Bothe, Gordana& Chong, Pee-Win& De Costa, Patricia…[et al.]. 2019. Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”. Journal of Obesity،Vol. 2019, no. 2019, pp.1-2.
https://search.emarefa.net/detail/BIM-1184894
Modern Language Association (MLA)
Uebelhack, Ralf…[et al.]. Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”. Journal of Obesity No. 2019 (2019), pp.1-2.
https://search.emarefa.net/detail/BIM-1184894
American Medical Association (AMA)
Uebelhack, Ralf& Bongartz, Udo& Seibt, Stephanie& Bothe, Gordana& Chong, Pee-Win& De Costa, Patricia…[et al.]. Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”. Journal of Obesity. 2019. Vol. 2019, no. 2019, pp.1-2.
https://search.emarefa.net/detail/BIM-1184894
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1184894
